Laman Utama4547 • TYO
add
Kissei Pharmaceutical Co Ltd
Tutup sebelumnya
¥4,040.00
Julat hari
¥3,920.00 - ¥4,025.00
Julat tahun
¥3,150.00 - ¥4,300.00
Permodalan pasaran
185.47B JPY
Bilangan Purata
83.36K
Nisbah P/E
14.53
Hasil dividen
2.51%
Pertukaran utama
TYO
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (JPY) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 22.66B | 27.88% |
Perbelanjaan pengendalian | 9.41B | 5.46% |
Pendapatan bersih | 3.12B | 10.56% |
Margin untung bersih | 13.77 | -13.56% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 2.69B | 193.80% |
Kadar cukai berkesan | 22.69% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (JPY) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 48.65B | 5.92% |
Jumlah aset | 244.06B | -6.47% |
Jumlah liabiliti | 33.93B | -14.73% |
Jumlah ekuiti | 210.12B | — |
Syer tertunggak | 42.81J | — |
Harga kepada buku | 0.83 | — |
Pulangan pada aset | 1.56% | — |
Pulangan pada modal | 1.81% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (JPY) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 3.12B | 10.56% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
Diasaskan
9 Ogo 1946
Ibu pejabat
Tapak web
Pekerja
1,779
